Samir R. Patel - 31 Oct 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Wendy F. DiCicco, as Attorney-in-Fact
Issuer symbol
AKTX
Transactions as of
31 Oct 2024
Net transactions value
$0
Form type
4
Filing time
01 Nov 2024, 18:00:04 UTC
Previous filing
02 Oct 2024
Next filing
18 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKTX Stock Option (Right to Buy) Award $0 +79,684,000 $0.000000 79,684,000 31 Oct 2024 Ordinary Shares, par value $0.0001 per share 79,684,000 $0.001300 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options have an exercise price of $0.001255 per ordinary share, par value $0.0001 per share ("Ordinary Share").
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.